Will I lose muscle on a GLP-1? Some of the weight any GLP-1 takes off is lean mass and the amount is not fixed. The trials measured it and found an enormous range between patients who protect muscle and patients who do not. What separates them is protein and resistance training, the two levers you control. The third factor is a clinical protocol that tracks the whole picture of the loss and does not stop at the scale.
- In the STEP-1 body composition substudy roughly a quarter of the weight lost on semaglutide was lean mass, on average.
- The average hides a wide range and the difference is largely protein intake and resistance training.
- Muscle loss during weight loss raises the risk of regaining, because resting energy expenditure falls with lean mass.
- The Biomarker Audit reads metabolic and inflammatory markers alongside the weight trend every 90 days.
- Our fee never changes with the dose, so titration decisions carry no profit motive on our side.
What the trials actually measured
The STEP-1 body composition substudy measured participants on semaglutide with dual-energy X-ray absorptiometry and found that roughly 25 percent of the total weight lost was lean mass, on average, with the remainder fat. A comparable pattern appears in the weight-loss literature broadly, from bariatric surgery to intensive diet programs, so this is not a GLP-1 peculiarity. It is the physiology of losing weight in a calorie deficit without a deliberate plan to protect muscle.
An average of 25 percent is a misleading number in both directions. In a well-run program with protein at target and resistance training twice or three times weekly, the lean-loss share can be meaningfully lower. In a program of aggressive deficit with no training and protein drifting below target because appetite is suppressed, it can be higher. The medication sets the size of the deficit. You set the composition of what is lost.
Why the percentage matters more than the pounds
Muscle is not cosmetic and it is not the point of the therapy for most patients, but it is the metabolic organ that holds your resting energy expenditure up, your glucose disposal working and your ability to keep the loss off once the medication ends or tapers. Lean mass lost during weight loss lowers the number of calories you burn at rest, which means the same eating pattern that maintained your weight before the diet now produces a surplus. That is a mechanism of regain, not a willpower failure.
There is also the aging question. A patient starting a GLP-1 at 58 with low lean mass at baseline is playing a different game from one at 35 with a solid muscle base and the protocol should know which game it is playing. This is one more reason the Biomarker Audit reads the whole panel rather than the scale, because the metabolic markers tell the clinician what the composition of the loss looks like even when the scale number alone cannot.
The medication sets the size of the deficit. Protein and training set the composition of what is lost.
The plan that protects lean mass
Protein at target, every day. GLP-1 medications suppress appetite so effectively that protein intake drifts below target without anyone noticing and muscle cannot be maintained on what is not eaten. Your clinician sets the target and the practical trick, when appetite is low, is protein first at every meal rather than grazing on whatever is available.
Resistance training, two to three sessions a week. This is the strongest lever for protecting lean mass during weight loss and it raises resting energy expenditure, which also attacks the plateau problem. The standard evidence-based starting point is full-body sessions with progressive overload and the session count matters less than consistency.
A loss rate that is not reckless. Faster is not better. A deficit so aggressive that lean mass follows the fat produces a worse outcome than a moderate one that protects muscle and the clinician titrating to the lowest effective dose is doing exactly this calculus. Our fee never changes with the dose, so the titration decision has no profit motive on our side, which matters because the lowest dose that gets the result is often also the dose that best protects lean mass.
Sleep and recovery. Poor sleep degrades muscle protein synthesis and drives the cortisol state that works against everything else on this list. It is the boring lever and it belongs on the checklist.


Why quarterly labs belong in this conversation
The scale cannot tell you what was lost. Neither can the mirror. The clinical answer is to read the metabolic and inflammatory markers that move with body composition, alongside the weight trend, every 90 days. Hs-CRP falls as visceral fat falls. Fasting insulin improves with glucose disposal. Hemoglobin A1c follows the same line. When those markers move well while weight falls, the loss is likely a good composition. When weight falls fast and the metabolic markers stall, the conversation changes before lean mass is gone.
In a per-visit system this data is expensive and nobody orders it. In the membership it is the product, four audits a year, included in the flat fee, read by the clinician who titrates the dose.
What the membership costs, stated plainly
The Cardiometabolic Optimization Membership is one flat $299 per month covering the clinical relationship and four quarterly Biomarker Audits a year. It starts with a two month commitment paid as a single $598 hold covering the first two months together, charged only once a clinician accepts you into care. If no clinician can accept you, the hold is released and you are never charged. Once accepted, the first two months are non-refundable. From month three the membership is month to month and you can cancel anytime.
Medication is a separate charge and it never flows through us. Any prescription is written to the pharmacy you choose and billed by that pharmacy at its own price. GoodLife Health sets nothing, sees nothing and takes nothing on that transaction. There is no molecule upcharge and no dose upcharge, ever. One flat fee for the doctor. Zero markup on the medicine. The eligibility check is free and takes a few minutes.
Frequently Asked Questions
Will I lose muscle on a GLP-1?
Some lean mass is lost in any substantial weight loss and GLP-1 trials are no exception. In the STEP-1 body composition substudy roughly a quarter of the weight lost was lean mass, on average. How much you lose personally depends heavily on protein intake and resistance training, which are the two levers you control.
How much of the weight lost on semaglutide is muscle?
The STEP-1 substudy measured roughly 25 percent of total weight lost as lean mass on average. That average hides a wide range. The difference between a good and a poor outcome is largely behavior, protein at target and resistance training during the loss.
How do I prevent muscle loss on a GLP-1?
Protein at target every day, resistance training two to three times a week, adequate sleep and a rate of loss that is not so aggressive that lean mass follows the fat. Your clinician can set those targets and the quarterly audit tracks whether the plan is working.
How much protein do I need on a GLP-1?
General guidance for active adults in a weight-loss phase is higher than the sedentary RDA, commonly in the range of 0.54 to 0.73 grams per pound of body weight per day, but your specific target belongs to your clinician, especially with reduced appetite making intake harder.
Does resistance training matter that much?
Yes. It is the strongest lever you have for protecting lean mass during weight loss and it raises resting energy expenditure, which also helps the plateau problem. Two to three sessions a week is the standard evidence-based starting point.
How does GoodLife Health monitor muscle health?
The quarterly Biomarker Audit tracks metabolic and inflammatory markers alongside the weight trend and the clinician titrates to protect lean mass rather than maximize scale movement.
How much does the membership cost?
One flat $299 per month covering the doctor and four quarterly lab audits a year, after a two month start paid as one $598 charge covering the first two months together. Medication is billed by your pharmacy separately at pharmacy cost with zero markup.
One last thing
The scale cannot tell you what was lost and the mirror is not much better. The honest weight-loss program tracks the composition of the loss with quarterly labs and a clinician whose income does not depend on the dose. That is the model and the eligibility check is where it starts.
Related Guides
- Why did my GLP-1 plateau and what should I do next?
- Medical weight loss
- What a Biomarker Audit includes
- Cardiometabolic Optimization: the definitive guide
References
- STEP 1 trial body composition substudy, 2022. pubmed.ncbi.nlm.nih.gov/35196773
- SURMOUNT-1 trial, tirzepatide in adults with obesity, New England Journal of Medicine, 2022. nejm.org